Neurology Devices are specialized surgical devices used for the treatment of disease or conditions of Central Nervous System (CNS) and spine. Dura Substitutes are patches which are used as sheet or material in repairing the dura mater. GlobalData uses proprietary data and analytics to provide a comprehensive report on the dura substitutes market in New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the dura substitutes market in New Zealand was B. Braun Melsungen followed by Integra LifeSciences, DePuy Synthes, Medtronic, Regenity Biosciences and Baxter International.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Closure or repair of dura mater is essential to prevent a Cerebrospinal Fluid (CSF) leak. Biological Dura Substitutes and Synthetic Dura Substitutes are tracked under this segment. Biological Dura Substitutes are made by bio engineering of tissues from different animals such as cow (bovine pericardium) and pig (porcine intestinal sub mucosal layer). Synthetic Dura Substitutes are made from polymer materials such as Polytetrafluoroethylene (PTFE) and have high tensile strength.
The dura substitutes market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size dura substitutes in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
